P450
Cytochrome P450 are a family of heme-containing monoxygenases catalyzing the metabolism of xenobiotics in the body where P450 enzymes use O2 and two electrons provided by NAD(P)H with the help of redox partner flavoproteins and iron-sulfur proteins to catalyze the monooxygenation of a variety of substrates. Based on how electrons from NAD(P)H are delivered to the catalytic site, P450 enzymes are divided into four classes, including Class I requiring both an FAD-containing reductase and an iron sulfur redoxin, Class II requiring only an FAD/FMN-containg P450 reductase, Class III requiring no electron donor and Class IV requiring electrons directly from NAD(P)H.
P450 相关产品(439)
- GC36822OteseconazoleCAS: 1340593-59-0纯度: >99.50%
Oteseconazole (VT-1161) 是一种有效、可口服的抗真菌剂,有效结合并抑制白色念球菌的 CYP51 (Kd,<39 nM),但对人 CYP51 无明显作用。
- GC37061QuilseconazoleCAS: 1340593-70-5
Quilseconazole (VT-1129) 是一种有效、可口服的真菌 Cyp51 (fungal Cyp51) 抑制剂,能够与隐球菌的 Cyp51 紧密结合,但对人 Cyp51 的抑制作用很弱。
- GC37631SeviteronelCAS: 1610537-15-9纯度: >99.50%
Seviteronel (VT-464) 是 CYP17 裂解酶抑制剂,对h-Lyase的 IC50 为 69 nM。
- GC37632Seviteronel racemateCAS: 1375603-36-3纯度: >98.00%
Seviteronel racemate (VT-464 racemate) 消旋体是 Seviteronel (VT-464) 的外消旋形式。
- GC38554Liarozole dihydrochlorideCAS: 1883548-96-6纯度: >99.00%
Liarozole dihydrochloride 是一种 P-450 抑制剂,视黄酸 (RA) 代谢阻断剂可抑制 RA 代谢,从而增加活跃产生 RA 的细胞中的细胞内 RA 水平。
- GC38758ClomethiazoleCAS: 533-45-9纯度: >98.00%
Chlormethiazole 是一种有效的口服 GABAA 激动剂。 Chlormethiazole 还可以抑制人肝微粒体中的细胞色素 P450 亚型: CYP2A6 和 CYP2E1。Chlormethiazole 有抗惊厥作用,具有治疗惊厥性癫痫的潜力。
- GC39168GSK2945 hydrochloride纯度: >99.50%
GSK2945 hydrochloride 是一类叔胺,是一种高度特异性的 Rev-erbα/REV-ERBα (小鼠/人反向成红细胞病病毒α) 拮抗剂, 其 EC50 值分别为 21.5 μM 和 20.8 μM。GSK2945 hydrochloride 可增强胆固醇 7α-羟化酶 (CYP7A1) 水平和胆固醇代谢。
- GC40112(±)-Climbazole-d4CAS: 1185117-79-6纯度: >99.00%
An internal standard for the quantification of climbazole
- GC40228Fluvastatin-d6 (sodium salt)纯度: >95.00%
An internal standard for the quantification of fluvastatin
- GC40360(±)14(15)-EpETECAS: 131339-24-7纯度: >90.00%
An EPA congener of (±)14(15)-EpETrE with EDHF activity
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC36754 | N-Nornuciferine | 4846-19-9 | >98.00% | |
An alkaloid with cholinesterase inhibitory activity | ||||
| GC36822 | Oteseconazole | 1340593-59-0 | >99.50% | |
Oteseconazole (VT-1161) 是一种有效、可口服的抗真菌剂,有效结合并抑制白色念球菌的 CYP51 (Kd,<39 nM),但对人 CYP51 无明显作用。 | ||||
| GC37061 | Quilseconazole | 1340593-70-5 | - | |
Quilseconazole (VT-1129) 是一种有效、可口服的真菌 Cyp51 (fungal Cyp51) 抑制剂,能够与隐球菌的 Cyp51 紧密结合,但对人 Cyp51 的抑制作用很弱。 | ||||
| GC37631 | Seviteronel | 1610537-15-9 | >99.50% | |
Seviteronel (VT-464) 是 CYP17 裂解酶抑制剂,对h-Lyase的 IC50 为 69 nM。 | ||||
| GC37632 | Seviteronel racemate | 1375603-36-3 | >98.00% | |
Seviteronel racemate (VT-464 racemate) 消旋体是 Seviteronel (VT-464) 的外消旋形式。 | ||||
| GC37727 | Talarozole R enantiomer | 870093-23-5 | - | |
Talarozole R enantiomer是一个强的,有选择性的细胞色素P450,CYP26的抑制剂。 | ||||
| GC38421 | Phillyrin (Forsythin) | 487-41-2 | >98.50% | |
A lignan with diverse biological activities | ||||
| GC38554 | Liarozole dihydrochloride | 1883548-96-6 | >99.00% | |
Liarozole dihydrochloride 是一种 P-450 抑制剂,视黄酸 (RA) 代谢阻断剂可抑制 RA 代谢,从而增加活跃产生 RA 的细胞中的细胞内 RA 水平。 | ||||
| GC38623 | Fraxinol | 486-28-2 | - | |
A coumarin | ||||
| GC38681 | Cedrol | 77-53-2 | >98.00% | |
A sesquiterpene alcohol | ||||
| GC38758 | Clomethiazole | 533-45-9 | >98.00% | |
Chlormethiazole 是一种有效的口服 GABAA 激动剂。 Chlormethiazole 还可以抑制人肝微粒体中的细胞色素 P450 亚型: CYP2A6 和 CYP2E1。Chlormethiazole 有抗惊厥作用,具有治疗惊厥性癫痫的潜力。 | ||||
| GC39168 | GSK2945 hydrochloride | - | >99.50% | |
GSK2945 hydrochloride 是一类叔胺,是一种高度特异性的 Rev-erbα/REV-ERBα (小鼠/人反向成红细胞病病毒α) 拮抗剂, 其 EC50 值分别为 21.5 μM 和 20.8 μM。GSK2945 hydrochloride 可增强胆固醇 7α-羟化酶 (CYP7A1) 水平和胆固醇代谢。 | ||||
| GC39746 | (3S,5S)-Atorvastatin | 501121-34-2 | >95.00% | |
An enantiomer of atorvastatin | ||||
| GC40112 | (±)-Climbazole-d4 | 1185117-79-6 | >99.00% | |
An internal standard for the quantification of climbazole | ||||
| GC40228 | Fluvastatin-d6 (sodium salt) | - | >95.00% | |
An internal standard for the quantification of fluvastatin | ||||
| GC40258 | Tetrahydropiperine | 23434-88-0 | >97.00% | |
A derivative of piperine | ||||
| GC40268 | (±)14(15)-DiHET | - | >98.00% | |
A urinary metabolite of (±)14(15)-EET | ||||
| GC40272 | (±)8(9)-DiHET | 192461-96-4 | >98.00% | |
A CYP450 metabolite of arachidonic acid | ||||
| GC40279 | (±)11(12)-DiHET | - | >98.00% | |
An epoxide metabolite and potent vasodilator | ||||
| GC40301 | Tamoxifen N-oxide | 75504-34-6 | >98.00% | |
A metabolite of tamoxifen | ||||
| GC40341 | Tetrahydro-11-deoxy Cortisol | 68-60-0 | >95.00% | |
A metabolite of 11-deoxycortisol | ||||
| GC40360 | (±)14(15)-EpETE | 131339-24-7 | >90.00% | |
An EPA congener of (±)14(15)-EpETrE with EDHF activity | ||||
| GC40363 | (±)5(6)-DiHETE lactone | - | >90.00% | |
A lactone form of (±)5(6)-DiHETE | ||||
| GC40365 | (±)8(9)-EpETE | 851378-93-3 | >95.00% | |
Epoxygenase metabolite of EPA | ||||
